Primary aldosteronism (PA) is the most frequent form of secondary arterial hypertension. Mutations in different genes increase aldosterone production in PA, but additional mechanisms may contribute to increased cell proliferation and aldosterone producing adenoma (APA) development. We performed transcriptome analysis in APA and identified retinoic acid receptor alpha (RARα) signaling as a central molecular network involved in nodule formation. To understand how RARα modulates adrenal structure and function, we explored the adrenal phenotype of male and female Rarα knockout mice. inactivation of Rarα in mice led to significant structural disorganization of the adrenal cortex in both sexes, with increased adrenal cortex size in female mice and increased cell proliferation in males. Abnormalities of vessel architecture and extracellular matrix were due to decreased Vegfa expression and modifications in extracellular matrix components. On the molecular level, Rarα inactivation leads to inhibition of non-canonical Wnt signaling, without affecting the canonical Wnt pathway nor PKA signaling. Our study suggests that Rarα contributes to the maintenance of normal adrenal cortex structure and cell proliferation, by modulating Wnt signaling. Dysregulation of this interaction may contribute to abnormal cell proliferation, creating a propitious environment for the emergence of specific driver mutations in PA.
Results
Decrease of retinoic acid receptor α expression is associated with nodulation in APA. We compared the transcriptome profile of 48 APA and 11 control adrenals. Unsupervised clustering revealed the presence of at least three different groups of samples (Fig. 1A ). The first one being composed exclusively of control adrenals, whereas the 48 APA were subdivided into two groups of 43 and 5 samples defined as APA group A (APA_A) and APA group B (APA_B), respectively. The APA_B is spatially separated from the rest of the samples (Fig. 1B) , and from this perspective control adrenals seem to be very similar to samples in APA_A. However, using the first three dimensions of a Principal Component Analysis (PCA), APA_A are clearly separated from control adrenals and from APA_B (Fig. 1C) . By comparing clinical and biochemical characteristics of patients from APA_A and APA_B, we found no difference between groups except for the tumor size [15 mm (9-18) for APA_A versus 40 mm (32-52.5) for APA_B (Table 1) ]. Interestingly, another major difference characterizing these two groups of tumors was the level of expression of CYP11B2 (aldosterone synthase) detected by immunohistochemistry, sets to indicate the relative proportion of the overlapping regions to the corresponding list of candidate genes. Figures displayed are the number of genes that populate each of the selected sets. (F) Expression of RARα was investigated by RT-qPCR on mRNA extracted from 6 control adrenals and 19 APA. Values are presented as the mean ± SEM; p values were calculated using a two-sided Mann-Whitney test. *p < 0.05. (G) RARα immunohistochemistry performed on control adrenal and in APA.
which was higher in APA_A compared to APA_B (Fig. 1D ). The three groups were pairwise compared to obtain a list of statistically significantly differentially expressed genes for each of the three comparisons ( Supplementary  Tables 1-3 ). The common and comparison-specific genes were then classified into 7 different groups, some of which were associated to a specific biological process ( Fig. 1E and Supplementary Fig. 1 ; Supplementary Tables 4-10 ). In particular, we made the hypothesis that genes commonly differentially expressed in APA_A (high aldosterone production) and APA_B (low aldosterone production) compared to control adrenals would be involved in nodulation (Fig. 1E , subgroup 2) rather than steroid biosynthesis. Within this group, the expression of retinoic acid receptor α (RARα) was significantly down regulated in APA (logQ[APA_A vs CA] -3.8852; logQ[APA_B vs CA] -3.0056). RT-qPCR performed on 6 control adrenals and 19 APA confirmed the down-regulation of RARα mRNA expression in APA (Fig. 1F ). Immunohistochemistry showed that RARα was expressed throughout the adrenal cortex, and to a lesser extent in the medulla; its expression was heterogeneous in APA ( Fig. 1G ). Our transcriptome data also revealed that all the enzymes necessary for the biosynthesis of RA are expressed in control adrenal cortex as well as in APA (Table 2) , supporting the possibility of RA biosynthesis and action in the adrenal gland. Modulation of RARα target genes was investigated by retrieving, from our transcriptome data, the expression of 511 genes described as RARα target genes and expressed in humans 31 ( Supplementary  Table 11 ). Among them, 147 were found to be differentially expressed between APA_A and control adrenals (67 were up-regulated and 80 down-regulated) and 123 between APA_B and control adrenals (10 up-regulated and 113 down-regulated).
Significant disorganization of the adrenal cortex in 12 weeks old male and female Rarα −/− mice.
To evaluate the role of Rarα in adrenal cortex structure and function, we compared the adrenal phenotype of 12 weeks old male and female Rarα +/+ and Rarα -/mice. As previously described 32 , the Rarα -/mice exhibited growth retardation characterized by lower total body weight ( Table 3 ). Relative adrenal weight of Rarα +/+ and Rarα -/was similar in male mice, while it was significantly increased in female Rarα -/mice (Table 3) compared to wild type littermates. HES staining revealed marked disorganization of the adrenal cortex, characterized by a loss of the radial organization of the zona fasciculata (ZF) in both male and female mice ( Fig. 2A and Supplementary Fig. 2) , with a conserved zona glomerulosa (ZG). Confirming the HES observation, the expression of Disabled-2 (Dab-2), a marker of ZG 33 , was not affected in Rarα -/mice ( Fig. 2A,B) , indicating that only the ZF was affected in both males and females. We also investigated the expression of 20-αHSD, a marker of the fetal X-zone 34 , which regresses at puberty in males and after the first gestation in females. No modification of 20-αHSD expression was observed in Rarα -/mice compared to wild type littermates, with the X-zone being visible in females but not in males in both genotypes ( Supplementary Fig. 3 ), suggesting that the development and the regression of the fetal X-zone was unaffected. Total number of nuclei in adrenal cortex, indirectly reflecting adrenal cortex size, was significantly higher in 12 weeks old male and female Rarα -/mice ( Fig. 2C ). In males, this was associated with an increased proliferation, highlighted by an increase of Ki67 positive nuclei in the adrenal cortex in Rarα -/mice, ( Fig. 2A,D) . Although the proliferative index was not changed ( Fig. 2A ,D) in 12 weeks old female Rarα -/mice, the adrenal weight was significantly increased (Table 3 ) in addition to ZF expansion, suggesting that increased proliferation may have occurred at an earlier time point during development. Aldosterone synthase expression was found to be restricted to the ZG in both Rarα +/+ and Rarα -/male and female mice ( Fig. 3A ). Interestingly, in both sexes, the localization of 11β-hydroxylase was not modified, despite ZF disorganization ( Fig. 3A) . However, the expression of genes coding for steroidogenic enzymes, including Star ( 
Modification of vessel architecture and extra cellular matrix composition in Rarα −/− mice.
To gain mechanistic insight into the activity of Rarα in the adrenal cortex, microarray analysis was performed on adrenals from four Rarα +/+ and four Rarα -/male mice. Hierarchical clustering allowed separating three out of four Rarα -/mice from WT mice ( Fig. 4A,B ). Among the 243 statistically significantly differentially expressed genes, 184 genes (75.72%) were found to be upregulated and 59 (24.28%) down-regulated. Gene Ontology analyses allowed the identification of specific molecular functions and biological processes enriched in 12 weeks Rarα +/+ versus Rarα -/mice ( Supplementary Fig. 2 ), which are mainly involved in specific metabolic processes, such as lipid, carboxylic acid or fatty acid metabolism. Interestingly, among the differentially regulated genes, Vegfa mRNA expression was found to be downregulated in Rarα -/mice compared to Rarα +/+ mice ( Fig. 4B , Supplementary Table 12 ). The down-regulation of Vegfa mRNA expression was confirmed by RT-qPCR in male mice only (Fig. 4C ). The expressions of Vegfc, involved in angiogenesis and lymphangiogenesis, and of Hif1α, a marker of hypoxia, were unchanged ( Fig. 4D ,E). Sirius red staining, performed in male mice, revealed dilatation of vessels ( Fig. 4F ). In addition, podocalyxin staining of endothelial cells revealed disorganization of vessel architecture in both male and female Rarα -/mice ( Fig. 4F ). Expression of fibronectin 1, microfibrillar associated protein 2 and 5 (Mfap2 and Mfap5) and of collagen 3α1, all components of the extracellular matrix (ECM), was found to be up-regulated in male Rarα -/mice ( Supplementary Table 12 ). To evaluate if Rarα inactivation alters ECM structure, laminin β1 staining was performed. Laminin β1, a component of the basement membrane of the ECM, was expressed homogeneously throughout the adrenal cortex in both male and female Rarα +/+ mice www.nature.com/scientificreports www.nature.com/scientificreports/ ( Fig. 4F ). In Rarα -/mice, expression of laminin β1 showed a gradient, with higher expression in the ZG than in the inner part of the ZF in male but not in female mice (Fig. 4F ). Since expression of laminin β1 was not modified in microarray analyses, this suggests that modification of the expression of other components of the ECM may alter proper laminin β1 localization. of the ZF (Fig. 5A ). In male Rarα -/mice, high expression of β-catenin was observed in the outer layer of the adrenal cortex, extending into the ZF (Fig. 5A ); the localization of β-catenin was unaffected in female Rarα -/mice ( Fig. 5A ). Western blot performed on whole adrenals showed that the expression of β-catenin was not significantly increased in male and female Rarα -/mice compared to wild type littermates ( Fig. 5B,C) , although a large variation of its expression was observed in male Rarα -/mice ( Fig. 5C ) consistent with the extended localization observed in some animals. β-catenin phosphorylation is a marker of its activation state; phosphorylation on inactivating (T41/S45) ( Fig. 5D ) or activating (S552, S675) ( Fig. 5E ,F) residues was not affected by Rarα expression, indicating absence of activation of the canonical Wnt/β-catenin pathway in Rarα -/mice. This was also supported by unchanged mRNA expression of Axin2 (Fig. 5J ), a target gene of the canonical Wnt/β-catenin pathway. In contrast, mRNA expression of Wnt4 (Fig. 5G ), Tcf3 (Fig. 5H) and Lef1 (Fig. 5I ), effectors and targets of non-canonical Wnt signaling, was reduced in adrenals from 12 weeks old Rarα -/male mice. Modification of the expression of Wnt4 (Fig. 5G ), a ligand involved in non-canonical Wnt signaling, of Frizzled-2, a transmembrane www.nature.com/scientificreports www.nature.com/scientificreports/ receptor of the non-canonical pathway ( Supplementary Table 12 ) and of Tcf3 (Fig. 5H ), a transcription factor that can act as a transcriptional repressor independently of β-catenin binding, suggests that the non-canonical Wnt signaling pathway is altered in Rarα -/mice. www.nature.com/scientificreports www.nature.com/scientificreports/ Since Rarα -/mice show significant abnormalities of the ZF, we also explored protein kinase A (PKA) activation, which plays an important role in adrenal cortex development and function. It has been proposed that PKA prevents ZG differentiation through Wnt pathway inhibition, suggesting that PKA activation in the ZF is a key driver of Wnt inhibition 35 . PKA is the main kinase responsible for the phosphorylation of specific transcription factors including the cAMP response element-binding protein (CREB) 36 . p-CREB was detected in the entire cortex in Rarα +/+ and Rarα -/-( Supplementary Fig. 4 ), where its expression was detected in >70% of the cells ( Supplementary Fig. 4 ). Western blot analysis of CREB and p-CREB expression, performed on whole adrenals, revealed no change in total CREB expression or in its phosphorylation status depending on genotype ( Supplementary Fig. 4 ). mRNA expression of Prkar1a and Prkaca, the genes coding for the regulatory and catalytic subunit of PKA, was reduced in Rarα -/animals ( Supplementary Fig. 4 ); given the concomitant modification of both subunits, this did not affect the expression of S100a4, a target gene of PKA activation in the adrenal 37 ( Supplementary Fig. 4 ).
Inhibition of Wnt signaling in young Rarα

Significant disorganization of the adrenal cortex persists with aging.
As Rarα was identified as associated with abnormal cell proliferation and nodule formation in APA, we evaluated the evolution of adrenal abnormalities with aging by investigating the adrenal phenotype of Rarα -/animals at 52 weeks of age ( Fig. 6 and Supplementary Fig. 5 ). Growth retardation was more pronounced in 52 weeks old compared to 12 weeks www.nature.com/scientificreports www.nature.com/scientificreports/ old mice, with smaller weight for both male and female Rarα -/compared to Rarα +/+ mice; the relative adrenal weight was similar in both genotypes (Table 3) . Adrenal morphology and size, evaluated by magnetic resonance imaging, was also similar in both genotypes and sexes (Table 3 ). Similar to 12 weeks old Rarα -/-, we observed loss of radial organization of the ZF with a conserved ZG in both male and female mice at 52 weeks of age ( Fig. 6A,B) , and absence of the fetal X-zone in both genotypes ( Supplementary Fig. 3 ). However, at 52 weeks, the proliferation index and adrenal cortex size were similar in Rarα -/mice compared to their wild type littermates ( Fig. 6C,D) . No differences were observed in the localization of aldosterone synthase or 11 β-hydroxylase expression ( Fig. 6A ). Unlike 12 weeks old animals, there was no difference in the expression of steroidogenic genes such as Star (Fig. 6E) , Cyp11a1 (Fig. 6F ), and Cyp11b2 (Fig. 6H) in Rarα -/mice; a slightly decreased expression of Cyp11b1 (Fig. 6G ) was observed in female mice only. Again, plasma aldosterone ( Fig. 6I ) and corticosterone ( Fig. 6J ) levels, plasma renin concentration ( Fig. 6K ) and aldosterone to renin ratio (Fig. 6L) were not different in Rarα -/mice. However, 50% of male Rarα -/mice showed high plasma aldosterone concentrations (up to 1000 pmol/l), which were associated with higher plasma renin concentration (Fig. 6K ).
Vessel dilatation (Sirius red) and disorganization (podocalyxin) as well as abnormal laminin β1 localization were still present in both male and female mice ( Supplementary Fig. 5 ), but expression of Vegfa was not modified in Rarα -/mice at 52 weeks of age ( Supplementary Fig. 5 ). β-catenin was localized to the ZG ( Supplementary  Fig. 5 ), with an extended expression in ZF that could be observed in restricted areas in some animals (data not shown). Consistently with this observation, despite similar β-Catenin protein levels in Rarα +/+ and Rarα -/mice ( Supplementary Fig. 5 ), a large variation in its expression was observed ( Supplementary Fig. 5 ). Again, β-Catenin phosphorylation on activating (pS552 and pS675, Supplementary Fig. 5 ) or inactivating (pT41/S45, Supplementary Fig. 5 ) residues were unchanged, indicating again that canonical Wnt/β-Catenin signaling was not modified in 52 weeks old Rarα -/mice. In contrast to 12 weeks old Rarα -/mice, only the expression of Lef1 was reduced in 52 weeks old male Rarα -/mice ( Supplementary Fig. 5 ), while the expression of Wnt4 ( Supplementary  Fig. 5 ), Tcf3 ( Supplementary Fig. 5 ) and Axin 2 ( Supplementary Fig. 5 ) was similar in both genotypes. Similar to 12 weeks old mice, PKA signaling was unaltered at 52 weeks of age ( Supplementary Fig. 4 ). However, p-CREB expression was reduced (<20% of cells, Supplementary Fig. 4 ) and found to be restricted to the external part of the adrenal cortex, mainly the ZG, in both Rarα +/+ and Rarα -/animals at that age ( Supplementary Fig. 4 ).
Microarray analysis performed on adrenals from four Rarα +/+ and four Rarα -/-52 weeks old male mice revealed that 63 genes (60%) were upregulated and 42 (40%) down-regulated in Rarα -/mice. Despite the low number of differentially regulated genes, hierarchical clustering allowed separating adrenals form Rarα +/+ and Rarα -/mice ( Supplementary Fig. 6 ). The expression of some genes involved in retinoic acid biosynthesis was found to be increased (alcohol dehydrogenease 1 and 7), possibly to compensate for the lack of Rarα expression ( Supplementary Table 13 ). Furthermore, the expression of Mrap (Melanocortin 2 receptor accessory protein) was also found to be upregulated in these mice. Mrap has recently been shown to play a role in adrenal cortex zonation through the modulation of adrenal progenitor cell differentiation. Absence of Mrap was found to be associated to Wnt4/β-Catenin pathway dysregulation in ZG cells, showing an involvement of both the canonical and the non-canonical Wnt/β-Catenin pathway in adrenal gland zonation 38 .
Discussion
Several germline and somatic mutations cause excessive aldosterone production in PA. Although the functional link between those mutations and aldosterone production has been clearly established, the mechanisms leading to nodule formation appear to be complex and to partly involve different mechanisms 39 . Here we report the identification of RARα as being a key element in the regulation of adrenal cortex structure and cell proliferation. Inactivation of Rarα in mice led to significant structural disorganization of the adrenal cortex in male and female, with increased adrenal cortex size in female mice and increased cell proliferation in males, but no major modifications of aldosterone production. This disorganization is associated with modifications of the vessel architecture and ECM due to decreased Vegfa expression and modifications in ECM components. On the molecular level, Rarα inactivation leads to inhibition of the non-canonical Wnt signaling, without affecting the canonical Wnt Pathway nor PKA signaling. These molecular abnormalities were detected at 12 weeks in male mice only, suggesting that in female mice they may have occurred earlier in adrenal cortex development. At 52 weeks of age, the marked disorganization of the adrenal cortex persists in absence of molecular abnormalities in Wnt or Vegf signaling.
RAR belongs to the super-family of nuclear receptors; there are three subtypes of RAR: α (NR1B1), β (NR1B2) and γ (NR1B3). RAR functions as a ligand dependent transcription factor, which heterodimerizes with another receptor of the same family, the retinoic X receptor (RXR). RXR/RAR heterodimers bind to specific DNA sequences, the retinoic acid (RA) response element (RAREs) composed of two direct repeats of a core hexameric motif (A/G) G [G/T] TCA located in the regulatory regions of target genes 40, 41 . In the absence of ligand, RARs are bound to RAREs in association with large protein complexes, which maintain chromatin in a condensed and repressed state 42 . Ligand binding is facilitated by association of RAR with cellular RA binding proteins. This binding induces conformational changes in the ligand-binding domain of the receptor, resulting in corepressor release and coordinated recruitment of a series of coregulator complexes.
RA mediated transcription plays critical roles in a variety of biological processes, including development, reproduction, immunity, organogenesis and homeostasis 43 . Moreover RARs are involved in cancer development, due to mutations, fusions to other proteins, altered expression or aberrant post-translational modifications. These alterations result in modified function and disruption of homeostasis, due to the capacity of RAR to regulate growth and differentiation. In human myeloid leukemia, the RARα gene is the target of chromosomal rearrangements resulting in the production of fusion proteins that allow the cells to continue to proliferate and/or prevent the terminal differentiation seen in normal myelocytes 44 . Considering the associations between RAR and tumorigenesis, RAR are considered as tumor suppressor. In some cases, RAR have been correlated with survival instead 45 . Moreover, transcriptome analysis identified LPS/IL-1 mediated inhibition of RXR function pathway in the top 5 canonical pathways associated with genes differentially regulated in APA compared with adjacent ZG, suggesting a role of RXR pathways in APA 46 .
RA is a derivative of vitamin A (retinol), which is provided exclusively by diet. Vitamin A is converted into retinal by the action of alcohol dehydrogenases and short chain dehydrogenases/reductases. Then retinal is oxidized into RA by retinaldehyde dehydrogenase 47 . In mice, the half-life of RA has been estimated to be about 0.5 hours whereas retinol′s half-life is longer (3.6 hours) 48 , suggesting that RA could be produced locally in target tissues instead of being transported. All components of retinoic acid biosynthesis were identified in human and mouse adrenals in this study, supporting RA biosynthesis and action in the adrenal gland. Our data support a role for Rarα signaling in regulating cell proliferation: indeed, 12 weeks old male Rarα -/mice show an increased proliferative index compared to wild type littermates. Despite no changes in proliferative index observed in female mice at 12 weeks of age, their adrenal weight was increased, suggesting that a proliferative phase may have occurred at earlier stages of adrenal development 24 .
The Wnt/β-catenin pathway is known to play an important role in embryonic development, stem cell maintenance, and differentiation in many tissues 22, [49] [50] [51] [52] . Depending on the Wnt-receptor complex formed, a β-catenin dependent (canonical pathway) or independent response (non-canonical pathway) is activated. In the canonical pathway, the binding of Wnt ligands (Wnt1, Wnt2, Wnt3a, Wnt8a, Wnt8b…) to specific frizzled -Low-density lipoprotein receptor-related protein (Lrp) complex leads to the dissociation of β-catenin from the degradation complex and its translocation into the nucleus where it induces the expression of specific target genes (Lef1, Axin 2, c-jun, Cyclin D1, c-myc…) 22 through binding to specific transcription factors (T-cell factor/lymphoid enhancer factor, Tcf/Lef). The Tcf/Lef family is composed of four members Tcf1, Lef1, Tcf3 and Tcf4. Whereas Tcf1 and Lef1 mediate transcriptional activation of Wnt target genes, Tcf3 acts as a transcriptional repressor, independently of β-catenin binding 53 . In addition to this canonical Wnt/β-catenin pathway, a non-canonical Wnt pathway has been described involving binding of other Wnt ligands (Wnt4, Wnt5a, Wnt5b, Wnt6, Wnt7a, Wnt7b and Wnt11) to frizzled receptors (Fzd2, Fzd3, Fzd4 and Fzd6), which signals through the c-Jun N-terminal kinase (JNK) and the Ca 2+ signaling pathways 22, 54 . Activation of the non-canonical pathway replaces Tcf1 by Tcf3 in the Tcf/Lef complex, changing the transcriptional program induced by Tcf/Lef binding to DNA 55 .
In the adrenal cortex, β-catenin expression is restricted to the ZG, suggesting a role for this pathway in the development of the adrenal cortex 56 . In Wnt4-deficient mice, a decrease in ZG cell number has been reported, resulting in a decrease of Cyp11b2 mRNA expression and aldosterone production. These mice also show ectopic expression of adrenal-like cells in the gonads, probably due to abnormal adrenocortical progenitor cell migration during development, suggesting a role for Wnt4 in cell sorting during development 57 . In our model, the expression of Wnt4 was highly correlated to the expression of Cyp11b2 in both male (r = 0.6015, p = 0.0064) and female (r = 0.5663, p = 0.0007) mice, supporting the role of Wnt4 in the regulation of Cyp11b2 expression. Similarly, the targeted disruption of β-catenin in steroidogenic Sf-1-expressing cells causes adrenal aplasia in newborn mice, further supporting a role for the Wnt/β-catenin pathway early in adrenal development 56 .
The marked disorganization of adrenal cortex structure observed in Rarα knockout mice, was associated to reduced expression of Lef1, Tcf3, Wnt4 and increased expression of Fzd2 ( Supplementary Table 12 ), all involved in non-canonical Wnt signaling, in 12 weeks old Rarα -/male mice. In contrast, β-catenin phosphorylation, which reflects the activation status of the canonical Wnt/β-catenin pathway, was unchanged. Interactions between the Wnt pathway and retinoic acid receptor signaling have been reported in some studies. Hence, in mouse embryonic stem cells, retinoic acid can concomitantly activate the non-canonical and inhibit the canonical Wnt pathway 55 . Similarly, the expression of Lef1, known to be regulated by the canonical Wnt pathway, can also be modulated by the non-canonical pathway 58 . In chondrocytes, retinoic acid, through RARα/RXRα activation, plays an important role in terminal differentiation through BMP2 and Wnt4 modulation 59 . More interestingly, retinoic acid has been proposed to inhibit β-catenin/Tcf activity downstream of β-catenin by inducing expression of secreted factors such as Wnt4 or Wnt11 60 . Increased expression of Tcf3, concomitantly with decreased expression of Tcf1 enhances the ability of Tcf3 to bind to specific Wnt response element, inducing changes in the transcriptional program of the cells 55 . Therefore, our results suggest that Rarα could contribute to the structural organization of the adrenal cortex through modification of the expression of Wnt4 and Tcf3, thus modulating the non-canonical Wnt pathway. Recently, downregulation of retinoic acid signaling (liver and retinoid X receptors LXR/RXR) was reported in adrenals of Siah1 KO mice. Siah1 KO mice exhibit severe disorganization of adrenal glands as well as increased aldosterone and corticosterone levels and vessel dilatation. Siah1 codes for an E3 ubiquitin-protein ligase mediating ubiquitination and subsequent proteasomal degradation of target proteins, including PIAS1. On a molecular level, the stabilisation of PIAS1 leads to the enhancing sumoylation of Sf1 61 and LXR 62 . Whereas, Sf1 sumoylation results in increased steroidogenesis, modification of retinoic acid signaling could contribute to adrenal cortex disorganization as well as vessel dilatation.
PKA signaling has been proposed to play a role in cell conversion from ZG to ZF and in maintenance of adrenal cortex zonation, acting through the modulation of the Wnt/β-catenin pathway, by inhibiting Wnt4 expression 35 . In 12 weeks old male Rarα -/mice, the mRNA expression of both the regulatory and catalytic subunits of PKA (Prkar1a and Prkaca respectively) was downregulated; however CREB phosphorylation was not affected, aldosterone (I) and corticosterone (J) concentration by mass spectrometry in male mice. (K,L) Plasma renin concentration (PRC) and aldosterone to renin ratio. Measure of plasma aldosterone, plasma corticosterone and plasma renin were done on 5-6 animals per group. Values are presented as means ± SEM. *p < 0.05; **p < 0.01. www.nature.com/scientificreports www.nature.com/scientificreports/ neither was the expression of S100a4, a specific adrenal target gene of PKA 37 , suggesting that PKA activity was not affected. Therefore, the observed inhibition of the Wnt pathway does not appear to be due to modifications of PKA activity, but rather to a direct effect of Rarα.
Transcriptome analysis of adrenals from 12 and 52 weeks old Rarα +/+ and Rarα -/mice, combined with specific staining revealed a decrease in Vegfa expression as well as abnormal vascular architecture. This was associated with a differential pattern of expression of laminin β1, which was present in the entire adrenal cortex in Rarα +/+ mice, whereas a gradient of expression was observed in Rarα -/mice with higher expression in the ZG than in the inner part of the ZF. The extracellular environment, in particular the vasculature and ECM, plays an important role in adrenal cortex structure and function, by modulating proliferation, migration, differentiation and survival of surrounding cells, but also steroidogenesis 63, 64 . The ECM consists of the basement membrane and the interstitial ECM. The ECM is composed of polysaccharides and extracellular proteins such as collagens, laminins and fibronectin, but also some bioactive compounds (growth factors, enzymes, chemoattractants and morphogens), that form a three-dimensional network 65 . Laminins were found to be uniformly distributed in human adrenal cortex 64, 66 ; they have been proposed to play a role in adrenocortical cell migration through their chemotactic and haptotactic properties 66 . Interestingly, presence of RARα response elements has been identified in the laminin β1 promoter indicating regulation of its expression by retinoic acid 67 . Different studies reported that retinoic signaling participates in the regulation of the expression of ECM proteins as well as of cell membrane ECM receptors in physiological and pathophysiological conditions 68 . The modification of expression of some components of the ECM such as Fibronectin 1, MFAP2, MFAP5 and of Collagen 3α1, associated to the modification of the pattern of expression of laminin β1 observed in the adrenal cortex of Rarα -/mice strongly suggest a rearrangement of the ECM in absence of Rarα expression. These alterations of ECM composition could contribute to the disorganization of the adrenal cortex observed in our model, by modulating adrenocortical and vascular cell migration.
The adrenal gland is a highly vascularized tissue, each cell being in contact with at least one endothelial cell, allowing rapid release of hormones into the blood stream. Blood vessels present a centripetal pattern from superficial arteries to the central vein 69 , following the radial organization of the adrenal cortex 70 . A characteristic feature of adrenal glands is the high expression of VEGF, which is produced by steroidogenic cells and is regulated by ACTH 71 . Interestingly, the Wnt pathway has also been involved in angiogenesis and vessel remodeling. It has been proposed that Wnt inhibition leads to vessel stability or regression whereas its activation could lead to angiogenesis or vessel remodeling 72, 73 . VEGF plays a central role to optimize vessel growth 74 ; more importantly, many studies reported an effect of retinoic acid on VEGF expression; however depending on the cell models and the experimental conditions retinoic acid inhibits or stimulates VEGF expression 75, 76 . Hence, the adrenal phenotype observed in Rarα -/mice could be explained by a direct effect of deficient Rarα signaling on Vegfa signaling and Laminin β1 expression or by the inhibition of Wnt signaling, that could in turn also affect Vegf signaling. These modifications of the extracellular microenvironment in Rarα KO mice suggest that Rarα may affect the interplay between steroidogenic cell differentiation and migration, vasculature and extracellular matrix.
The development of specific mouse models in recent years has allowed a better understanding of the mechanism of male adrenal cortex development 65, 77 ; however little is still known in female mice. Sex differences in adrenal physiology have been demonstrated by Heitzmann and co-workers 27 . Invalidation of the Task1 potassium channel leads to abnormalities of adrenal zonation and PA development, which occurs only in female mice after puberty. Testosterone treatment before puberty in female Task1 -/mice leads to normal adrenal zonation. Similarly, castration of male Task1 -/mice leads to abnormal zonation of the adrenal cortex similar to female Task1 -/mice. The comparison of gene expression profiles of male and female adrenals allowed the identification of a set of genes that are modulated according to sex and hormonal treatments 26 . These studies highlighted the critical role for sexual hormones in adrenal gland zonation and the existence of a sexual dimorphism. Comparison of the adrenal phenotype of male and female Rarα -/mice revealed sex-specific molecular differences in young mice despite similar morphological abnormalities in adrenal gland development. This sexual dimorphism could be due to a different timing of the action of Rarα in adrenal development, with Rarα signaling occurring earlier in female than in male. As suggested by the adrenal phenotype of Task1 -/mice, sexual hormones, such as estrogen and androgens, may play a role in adrenal development and modulate the effect of Rarα inactivation.
In summary, our study identifies RARα as contributing to the maintenance of normal adrenal cortex structure and cell proliferation by modulating Wnt signaling. The absence of adrenal nodules in 52 weeks old mice suggests that abnormal cell proliferation induced by the absence of RARα signaling is not enough to promote APA, but may constitute one of the elements involved in the pathogenesis of PA. We propose a model in which a homeostatic equilibrium between retinoic acid, Wnt and Vegf signaling pathways is required for the maintenance of normal adrenal cortex structure in a specific time-dependent manner that differs between males and females (Fig. 7) . In addition to previously reported regulators and to further elements that remain to be identified, Ddysregulation of this equilibrium in adult adrenals may contribute to abnormal cell proliferation, creating the propitious environment for the emergence of specific driver mutations in PA. Methods for screening and subtype identification of PA were performed according to institutional and Endocrine Society guidelines 78, 79 . In patients diagnosed with primary aldosteronism, a thin slice CT scan or MRI of the adrenal and/or an adrenal venous sampling were performed to differentiate between unilateral and bilateral form. All patients gave written informed consent for genetic and clinical investigation. and eleven control adrenals obtained from enlarged nephrectomies for renal carcinoma. Total RNA was isolated from frozen tissue using Trizol (Invitrogen) and then cleaned-up on silica columns using RNeasy Mini Kit (Qiagen). The integrity and quality of the RNA were systematically checked using an Agilent 2100 Bioanalyzer with the RNA6000 Nano Assay (Agilent Technologies). For APA samples, complementary RNA was synthesized from 15 μg of total RNA using the Chemiluminescent RT Labeling Kit (Applied Biosystems). For control adrenals, complementary cRNA was synthesized from 500 ng of total RNA using the NanoAmpTM RT-IVT Labeling Kit (Applied Biosystems). Samples were hybridized to microarrays using Applied Biosystems chemiluminescence detection kit according to the manufacturer's protocol. Acquisition of the chemiluminescence images and primary data analysis were done using Applied Biosystems Expression Array System Software v1.1.1. Microarray gene expression data from the primary analysis for each sample was median centered, log 2 transformed, model-adjusted, and quality controlled 80 . Mean expression profiles for each biological condition were obtained by variance-weighted averaging normalized expression values. Pairwised inter-array normalizations were carried out using the NeONORM method described previously 81 . Fold change values were expressed on log2 scale. P-values were determined based on a normal distribution hypothesis of signal intensities using standard Mice. Animal studies were conducted according to the guidelines and regulations formulated by the European Commission for experimental use (Directive 2010/63/EU) and were approved by the local Ethics committee of Paris Descartes University (N°17-020) and by the French Ministère de l′Enseignement Supérieur, de la Recherche et de l′Innovation (APAFIS authorization number #11509-201703281427107 v4). Rarα -/mice (constitutive homozygous deletion of exon 8 of Rarα gene, leading to inactivation of the protein) have been kindly provided by Dr Norbert Ghyselinck and Dr Pierre Chambon 32 . They were maintained and bred on a mixed background and littermates control animals were used in all experiments. All experiments were conducted on male and female mice between 12 and 52 weeks of age. Blood were collected in abdominal aorta in lithium-heparin blood collection tubes (Microvette CB300LH, Sarstedt). The right adrenals were frozen in liquid nitrogen and the left adrenals fixed in 4% paraformaldehyde.
Magnetic resonance imaging. Anesthesia was induced with 4% isoflurane and maintained at a 1% level during imaging. Magnetic resonance imaging was performed with a dedicated small-animal 4.7 Tesla MR system (Biospec 47/40 USR Brucker). The animals were placed in a supine position on a four-channel phased array receive coil inside a volume transmit coil (BruckerBiospin, Ettlingen, Germany). We performed two anatomic sequences (TurboRARA T2 and FISP) in two directions (coronal and sagittal) to optimized measurement of the size of the adrenal. The thickness of the slices was 0.7 mm and the resolution was 175×175 μm and 156×126 μm respectively.
Aldosterone, corticosterone and plasma renin concentration measurement in murine plasma
samples. For steroids quantification, 150 μl of heparinized murine plasma was skiped with 500 ng of stable isotope labeled internal standards for aldosterone and corticosterone. Following C18-based solid-phase-extraction, samples were subjected to LC-MS/MS analysis using a reversed-phase analytical column (Acquity UPLC ® C18, Waters, Milford, MA, USA) operating in line with a XEVO TQ-S triple quadrupole mass spectrometer (Waters Xevo TQ/S, Milford, MA, USA) in multiple reaction monitoring mode. Internal standards were used to correct for analyte recovery across the sample preparation procedure in each sample. Analyte concentrations were calculated from integrated chromatograms considering the corresponding responses determined in appropriate calibration curves in plasma matrix.
The plasma renin concentration was determined in murine plasma samples by determining the Ang I formation rate in the presence of excess of angiotensinogen, where it becomes solely dependent on the concentration of active renin. Therefore, diluted plasma was supplemented with an excess of recombinant murine angiotensinogen. Samples were incubated at 37°C in the presence of an Ang I stabilizing inhibitor cocktail for 60 minutes at 37°C. Following LC-MS/MS based quantification of Ang I as described 84 RNA extraction and RT-qPCR analysis. Total RNA was extracted using Janke and Kunkel's Ultra-Turrax T25 (IKA technologies, Staufen DE) in Trizol reagent (Ambion Life Technologies, Carlsbad CA) according to the manufacturer's recommendations. After deoxyribonuclease I treatment (Life Technologies, Calsbad CA), 500 ng of total RNA were retro-transcribed (iScript reverse transcriptase, Biorad, Hercules, CA). The quantitative qPCR was performed using SYBRgreen (Sso advanced universal SyBr Green Supermix, Biorad, Hercules, CA) on a C1000 touch thermal cycler of Biorad (CFX96 Real Time System) according to the manufacturer's instructions. Controls without template were included to verify that fluorescence was not overestimated from primer dimer formation or PCR contaminations. RT-qPCR products were analyzed in a post amplification fusion curve to ensure that a single amplicon was obtained. Normalization for RNA quantity and reverse transcriptase efficiency was performed against three reference genes (geometric mean of the expression of Ribosomal 18S RNA, β2-microglobulin and Ubiquitin C for mouse samples and 18S RNA, GAPDH and HPRT for human samples), in accordance with the MIQE guidelines 85 . Quantification was performed using the standard curve method. Standard curves were generated using serial dilutions from a cDNA pool of all samples. The following primers were used: 5′-CCCTGCCCTTTGTACACACC-3′ and 5′-CGATCCGAGGGCCTCACTA-3′ for 18S; 5′-ATTCACCCC CACTGAGACTG-3′ and 5′-TGCTATTTCTTTCTGCGTGC-3′ for mβ2-microglobulin; 5′-AGCCCAGTGTTA CCACCAAG-3′ and 5′-ACCCAAGAACAAGCACAAG-3′ for mUbiquitinC; 5′-GTGCTTCATCCACTG GCTGGAA-3′ and 5′-GTCTGCGATAGGACCTGGTTGA-3′ for mStAR; 5′-TGCTCAACCTGCCTCCA GACTT-3′ and 5′-ACTGGCTGAAGTCTCGCTTCTG-3′ for mCyp11a1; 5′-TGTATCGAGAGCTGGCAGAG-3′ and 5′-CCTGGATGGCATCCATTGAC-3′ for mCyp11b1; 5′-ACCTACAGTGGCATTGTG-3′ and 5′-GATTGCTGTCGTGTCAAC-3′ for mCyp11b2; 5′-CCCTGTCTTTGGGAAGGTGGTG-3′ and 5′-CACCTGC TGAAGAGATGGCGTATAC-3′ for mWnt4; 5′-CAGATGGTGGCCTGGATACT-3′ and 5′-CATCCCT GCTGTAGCTGTCA-3′ for mTcf3; 5′-AAATGGGTCCCTTTCTCCAC-3′ and 5′-TCGTCGCTG TAGGTGATGAG-3′ for mLef1; 5′-AGCCTAAAGGTCTTATGTGG-3′ and 5′-ATGGAATCGTCGGTCAGT-3′ for mAxin2; 5′-CCTGGTGGACATCTTCCAGGAGTACC-3′ and 5′-GAAGCTCATCTCTCCTATGTGCTGGC-3′ for mVegfa; 5′-GGGAAGAAGTTCCACCATCA-3′ and 5′-ATGTGGCCTTTTCCAATACG-3′ for mVegfc;
Paraffin-Embedded mouse adrenals from 12 and 52 week-old WT and KO male mice. Adrenal sections were deparaffinized in xylene and rehydrated through graded ethanol. To unmask the antigen, the slides were incubated in antigen unmasking solution (Vector laboratories Ltd) for 30 minutes at 98°C.
Immunofluorescence was performed for Dab2 (1/100, sc-13982, Santa Cruz Biotechnology), Laminin β1 (1/500, ab69633, Abcam), β-catenin (1/1000, 61054, BD Transduction Laboratories), p-Creb (1/800, 9198, Cell Signaling Technology), mouse Cyp11b2 (mCyp11b2, 1/100, generous gift from CE Gomez-Sanchez), mouse Cyp11b1 (mCyp11b1, 1/50, generous gift from CE Gomez-Sanchez) and mouse podocalyxin (1/100, AF1556, R&D Systems). Tissues were permeabilized by a treatment of 15 min with TBS 0.1% Triton X100. The sections were then blocked with 5% BSA diluted in TBS for Dab2, laminin β1, β-catenin and p-Creb or with 10% normal donkey serum diluted in TBS 0.1% Triton X100 for mCyp11b2 and mCyp11b1. Primary antibodies were diluted in 3% BSA diluted in TBS (for Dab2, laminin β1, β-catenin and p-Creb) or in 5% normal donkey serum and 10% normal rat serum diluted in TBS 0.1% Triton X100 (for mCyp11b2 and mCyp11b1) and incubated overnight at 4°C (for laminin β1, β-catenin, p-Creb, mCyp11b2 and mCyp11b1) or 1 h at room temperature (Dab2). Primary antibodies were detected with donkey anti-rabbit Alexa 594 (1/400 for Dab2, laminin β1 and p-Creb, 1/500 for mCyp11b2, A21207, Thermo Fisher), donkey anti-mouse Alexa 594 (1/400 for β-catenin, A21203, Thermo Fisher), Donkey anti-goat Alexa 594 (1/400 for mouse podocalyxin, A11058, Thermo Fisher) and Donkey anti-sheep Alexa 488 (1/500 for mCyp11b1, A11015, Thermo Fisher). Nuclei were conterstained using 4′,6-diamidino-2-phenylindole (DAPI) (1/5000, Roche Diagnostics GmbH).
Immunohistochemistry was performed for mouse Ki67 (1/200, RM-9106, Thermo Fisher), mouse 20-αHSD (1/5000, generous gift from Y Weinstein), human RARα (1/500, ab28767, Abcam) and human CYP11B2 (hCYP11B2, 1/100, generous gift from CE Gomez-Sanchez). Sections were incubated in 3% hydrogen peroxide (Sigma-Aldrich) for 10 min to inhibit endogenous peroxidases. Non-specific staining was blocked by incubating sections 30 min with 10% normal goat serum diluted in PBS for Ki67, 20-αHSD and RARα or 10% horse serum (HS) and 0.5% SDS diluted in Tris 0.1 M pH 7.4 for hCYP11B2. Primary antibodies were incubated overnight at 4°C: Ki67, 20-αHSD and RARα were diluted in 1% NGS or HS in PBS and CYP11B2 was diluted in 10% horse serum and 0.2% Tween 20 in Tris 0.1 M pH 7.4. Primary antibodies were detected by incubation for 30 min with affinity-purified goat anti-rabbit (1/400 for Ki67 and 20-αHSD; Vector Laboratories) or rabbit anti-goat (1/400 for RARα; Vector Laboratories) diluted in 1% normal goat serum in PBS or horse anti mouse (1/400 for hCYP11B2; Vector Laboratories) diluted in 10% horse serum and 0.2% Tween 20 in Tris 0.1 M pH 7.4. After incubation for 30 min with an avidin-biotin-peroxidase complex (Vectastain ABC Elite; Vector Laboratories), the slides were developed using diaminobenzidin (Vector Laboratories) and counter-stained using Hematoxylin Harris Heamatoxylin, RAL Diagnostics).
All microscopic examinations were done with a x10 and x20 objectives lens using Leica confocal or Vectra TM system.
Multispectral images were acquired using a Vectra ® automated imaging system and automatically quantified with InForm ® software (both Perkin Elmer). Results of quantification are expressed in percentage of Dab2 or Ki67 positive cells over total adrenal cortex cells. Statistical significance was assessed among groups using t test or Mann-Whitney.
Histological examination. Histological examination was performed on 6 μm sections stained with hematoxylin-eosin safran (HES) and with Sirius red. Microscopic examinations were done with a x10 and x20 objectives lens using Vectra TM system or with a x40 objective lens using confocal SP8 Leica microscope.
Western blot. Western Blot analysis was performed on mouse adrenals from 12 and 52 week-old WT and KO male mice. Total proteins were extracted using RIPA buffer (RB 4475, BioBasic Canada) with EDTA-free protease and phosphatase inhibitor (Bimake), proteins were then spun on a rotor for 30 min and centrifuged at 13000 rpm for 15 min, the proteins were then recovered and concentration determined using Bradford protein essay (Biorad). 10 µg of total proteins were loaded on 10% Acrylamide SDS-PAGE gel, transferred onto nitrocellulose membrane and tagged with the following antibodies: phospho-β-Catenin (Thr41/Ser45; 1/1000, 9565, Cell Signaling Technology), phospho-β-Catenin (Ser552; 1/1000, 5651, Cell Signaling Technology), phospho-β-Catenin (Ser675; 1/1000, 4176, Cell Signaling Technology), β-Catenin (1/1000, 8480, Cell Signaling Technology), phospho-CREB (Ser133; 1/1000, 9198, Cell Signaling Technology), CREB (1/1000, 9197, Cell Signaling Technology)anti-rabbit IgG, HRP-linked antibody (1/2000, 7074, Cell Signaling technology), β-actin (1/5000, 2228, Sigma-Aldrich) and anti-mouse IgG, HRP-linked antibody (1/5000, A90-146P, Bethyl Laboratories). The signals were developed by Clarity Max ™ Western ECL substrate (Biorad, Hercules, CA) and detected by Fujifilm Las-4000 mini Luminescent image analyzer (Fujifilm, Tokyo-Japan) and quantified by Multi gauge software (Fujifilm, Tokyo-Japan). Expression of the phosphoprotein was normalized to the expression of the corresponding total protein and the expression of total proteins was normalized to the expression of the housekeeping protein β-actin.
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(2019) 9:14677 | https://doi.org/10.1038/s41598-019-50988-2 www.nature.com/scientificreports www.nature.com/scientificreports/ Microarray analysis of mouse adrenal gene expression. Adrenal gene expression profiles for 16 mice (4 Rarα +/+ and 4 Rarα -/-12 weeks old mice and 4 Rarα +/+ and 4 Rarα -/-52 weeks old mice) were analyzed using Affymetrix Clariom S Mouse array. After validation of the RNA quality with Bioanalyzer 2100 (using Agilent RNA6000 nano chip kit), 100 ng of total RNA was reverse transcribed following the GeneChip ® WT Plus Reagent Kit (Affymetrix). Briefly, the resulting double strand cDNA was used for in vitro transcription with T7 RNA polymerase (all these steps are included in the WT cDNA synthesis and amplification kit of Affymetrix). After purification according to Affymetrix protocol, 5.5 μg of Sens Target DNA were fragmented and biotin labeled. After control of fragmentation using Bioanalyzer 2100, cDNA was then hybridized to GeneChip ® Clariom S Mouse (Affymetrix) at 45°C for 17 hours. After overnight hybridization, chips were washed on the fluidic station FS450 following specific protocols (Affymetrix) and scanned using the GCS3000 7G. The scanned images were then analyzed with Expression Console software (Affymetrix) to obtain raw data (cel files) and metrix for Quality Controls.
Analyses were performed using TAC (Transcriptome Analysis Console) software. Genes with adjusted P value <0.05 and log2 fold changes <-1 or >1 were considered to be down-or up-regulated.
Molecular function and biological process enrichment analyses were performed using Gene Ontology (www. geneontology.org). For the analyses, we used the list of differentially expressed genes in 12 or 52 weeks old Rarα +/+ and Rarα -/mice. The analysis criteria were kept as default values. The data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus and are accessible through GEO Series accesion number GSE136801 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE136801).
Statistics. Data are shown in mean ± SEM. Statistical significance was assessed between the groups using unpaired t-test or Mann-Whitney test (Prism, GraphPad Software, USA). A p-value <0.05 was considered statistically significant.
